deflazacort has been researched along with Allergic Conjunctivitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagnasco, M; Buscaglia, S; Canonica, GW; Ciprandi, G; Iudice, A; Pesce, GP | 2 |
2 trial(s) available for deflazacort and Allergic Conjunctivitis
| Article | Year |
|---|---|
Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test.
Topics: Adolescent; Adult; Allergens; Anti-Inflammatory Agents; Antigens, CD; Cell Adhesion Molecules; Conjunctivitis, Allergic; Double-Blind Method; Epithelium; Female; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Pregnenediones; Rhinitis, Allergic, Perennial; Time Factors | 1993 |
Protective effects of deflazacort on allergen-specific conjunctival challenge.
Topics: Acute-Phase Reaction; Adolescent; Adult; Allergens; Anti-Inflammatory Agents; Cell Count; Conjunctivitis, Allergic; Double-Blind Method; Eosinophils; Female; Humans; Lymphocytes; Male; Middle Aged; Neutrophils; Plant Extracts; Pregnenediones | 1993 |